| Dr William F Varr Iii, MD | |
|
220 Toll Gate Rd, Warwick, RI 02886-4418 | |
| (401) 732-6640 | |
| (401) 739-5265 |
| Full Name | Dr William F Varr Iii |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 40 Years |
| Location | 220 Toll Gate Rd, Warwick, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457456386 | NPI | - | NPPES |
| 9002956 | Medicaid | RI | |
| 0000002956 | Other | BCBS OF RI | |
| 34247 | Other | RI | DAVIS VISION |
| AA40708 | Other | HARVARD PILGRIM HEALTHCARE | |
| 180042613 | Other | RI | RR MEDICARE |
| 1108 | Other | RI | NHP OF RI |
| 732011 | Other | RI | TUFTS HEALTH PLAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 6734 (Rhode Island) | Primary |
| 207W00000X | Ophthalmology | 220290 (Massachusetts) | Secondary |
| Entity Name | Kent Ophthalmology, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003911967 PECOS PAC ID: 3173525136 Enrollment ID: O20070205000674 |
News Archive
ViroPharma Incorporated today announced that data from Phase 3 studies of Cinryze (C1 esterase inhibitor [human]) have been published in the August 5, 2010 issue of the New England Journal of Medicine. The paper entitled Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema by Dr. Bruce L. Zuraw et al. describes the safety and efficacy of Cinryze in treating and preventing attacks of hereditary angioedema. Cinryze is the first and only FDA-approved C1 esterase inhibitor therapy indicated for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), a rare, debilitating and potentially fatal disease; it is not approved by the FDA to treat acute angioedema attacks.
Two U.S. courts of appeals reached different decisions regarding the issue of whether the health law's subsidies can be used by consumers shopping for health coverage on the federal exchange, because their states opted against setting up their own online insurance marketplace.
Are we "Waiting for Godot"- A Metaphor for Covid-19 "Waiting for Godot", one of the greatest works of the Theater of the Absurd is used to illustrate the dystopic nature of our approach to COVID-19.
Kaiser Health News staff writer Phil Galewitz, working in collaboration with the PBS Newshour, reports: "The future of Medicaid - the state-federal workhorse of the nation's health system that provides health coverage to the poorest and sickest Americans - hangs in the balance on Election Day. President Barack Obama and Republican nominee Mitt Romney have vastly different approaches to the program."
The Medicines Company announced today that the Committee for Medicinal Products for Human Use (CHMP) has granted a positive opinion applicable to all Member States of the European Union/European Economic Area that will extend the use of Angiox (bivalirudin) to include patients with heart attacks (so-called ST segment elevation myocardial infarction (STEMI)) undergoing emergency heart procedures called primary percutaneous coronary intervention (PCI).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William F Varr Iii, MD 220 Toll Gate Rd, Warwick, RI 02886-4418 Ph: (401) 732-6640 | Dr William F Varr Iii, MD 220 Toll Gate Rd, Warwick, RI 02886-4418 Ph: (401) 732-6640 |
News Archive
ViroPharma Incorporated today announced that data from Phase 3 studies of Cinryze (C1 esterase inhibitor [human]) have been published in the August 5, 2010 issue of the New England Journal of Medicine. The paper entitled Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema by Dr. Bruce L. Zuraw et al. describes the safety and efficacy of Cinryze in treating and preventing attacks of hereditary angioedema. Cinryze is the first and only FDA-approved C1 esterase inhibitor therapy indicated for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), a rare, debilitating and potentially fatal disease; it is not approved by the FDA to treat acute angioedema attacks.
Two U.S. courts of appeals reached different decisions regarding the issue of whether the health law's subsidies can be used by consumers shopping for health coverage on the federal exchange, because their states opted against setting up their own online insurance marketplace.
Are we "Waiting for Godot"- A Metaphor for Covid-19 "Waiting for Godot", one of the greatest works of the Theater of the Absurd is used to illustrate the dystopic nature of our approach to COVID-19.
Kaiser Health News staff writer Phil Galewitz, working in collaboration with the PBS Newshour, reports: "The future of Medicaid - the state-federal workhorse of the nation's health system that provides health coverage to the poorest and sickest Americans - hangs in the balance on Election Day. President Barack Obama and Republican nominee Mitt Romney have vastly different approaches to the program."
The Medicines Company announced today that the Committee for Medicinal Products for Human Use (CHMP) has granted a positive opinion applicable to all Member States of the European Union/European Economic Area that will extend the use of Angiox (bivalirudin) to include patients with heart attacks (so-called ST segment elevation myocardial infarction (STEMI)) undergoing emergency heart procedures called primary percutaneous coronary intervention (PCI).
› Verified 2 days ago
Dr. Leah Lynn Kammerdiener, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 566 Toll Gate Rd, Warwick, RI 02886 Phone: 401-738-4800 Fax: 401-738-5183 | |
Barbara Dodsworth-feldman, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 618 Toll Gate Rd, Warwick, RI 02886 Phone: 401-738-4800 Fax: 401-738-0231 | |
Dr. Tatyana Serednyakova, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 566 Toll Gate Rd, Warwick, RI 02886 Phone: 401-738-4800 Fax: 401-738-8153 | |
Dr. Michael O'brien, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 566 Toll Gate Rd, Warwick, RI 02886 Phone: 401-738-4800 Fax: 401-738-8153 | |
Dr. Michael Motolko, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 618 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-0981 Fax: 401-732-4931 | |
Theresa Marie Tretter, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 566 Toll Gate Rd, Warwick, RI 02886 Phone: 401-738-4800 Fax: 401-738-8153 |